International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: Correlates of high Ad5 titers and implications for potential HIV vaccine trials

T. Christopher Mast, John W. Shiver, Lisa Kierstead et al.|Vaccine|2009

Cited by 276